Cargando…
High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy
The present study compared the prognostic value of the modified Glasgow prognostic score (mGPS) and high-sensitivity mGPS (HS-mGPS) in unresectable locally advanced esophageal squamous cell carcimona (LAESCC) patients treated with concurrent chemoradiotherapy (CCRT). The baseline data of 163 eligibl...
Autores principales: | Chen, Peng, Fang, Min, Wan, Qiuyan, Zhang, Xuebang, Song, Tao, Wu, Shixiu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725136/ https://www.ncbi.nlm.nih.gov/pubmed/29245945 http://dx.doi.org/10.18632/oncotarget.21734 |
Ejemplares similares
-
A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022) -
Short-Term Prognostic Efficacy of mGPS and LCS in Patients With Acute Heart Failure
por: Wang, Jing, et al.
Publicado: (2022) -
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study
por: Proctor, M J, et al.
Publicado: (2011) -
The Relationship between ECOG-PS, mGPS, BMI/WL Grade and Body Composition and Physical Function in Patients with Advanced Cancer
por: Dolan, Ross D., et al.
Publicado: (2020) -
Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer
por: Song, Tao, et al.
Publicado: (2015)